Toloxatone

This classification denotes an antidepressive agent, monoamine oxidase inhibitor, and oxazolidinone derivative with the molecular formula C11H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5T206015T5, chemically known as 2-oxazolidinone, 5-hydroxymethyl-3-(m-tolyl)- but generally known as toloxatone, which bears US NIH Compound Identifier 34521. European Medicines Agency schedules Toloxatone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11169MIG. World Health Organization schedules toloxatone in its Anatomical Therapeutic Chemical (ATC) Classification. TOLOXATONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule toloxatone under HS 29349990 and SITC 51579. As of Q4 2014, TOLOXATONE remains the US FDA Preferred Term for this commodity. Toloxatone bears US NLM identifiers UMLS ID C0076804 and NCI Concept Code C97715. SMILES: CC1=CC(=CC=C1)N2CC(OC2=O)CO.